Current Search Criteria: Intervention: mesna, cisplatin, etoposide, rituximab
Found 6 matching trials
Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL PHASE2 Objectives
The primary objective of this study is to:
• determine the com...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma PHASE2 The purpose of this study is to find out what effects new combinations of t...
Show More Status
Active Not Recruiting
Location
Arthur J.E. Child Comprehensive Cancer Centre
Learn More & Join Trial
FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma NA The purpose of this study is to evaluate:
1. whether an imaging test calle...
Show More Location
Tom Baker Cancer Centre
Learn More & Join Trial
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) PHASE2 The overall purpose of the study is to determine if MEDI-551, when used in ...
Show More Learn More & Join Trial
Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma PHASE3 Evaluation of the efficacy and safety of TQB2825 injection compared to immu...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma PHASE3 The goal of this clinical study is to assess whether axicabtagene ciloleuce...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial